MedTrace Logo

Electromagnetic Treatment For Bone Loss After Forearm Fracture

NCT00067834 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-12-23

No results posted yet for this study

Summary

This study will determine the usefulness of pulsing electromagnetic field (PEMF) technology to reverse or reduce the bone loss (osteopenia) that occurs in the forearm after fracture or surgery.

Conditions

  • Bone Disease, Metabolic
  • Osteopenia
  • Osteoporosis, Post-Traumatic

Interventions

DEVICE

Pulsing electromagnetic field (PEMF)

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    lead NIH

Principal Investigators

  • Joseph A. Spadaro, PhD · Upstate Medical University Orthopedic Research Lab

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-11-30
Completion
2006-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00067834 on ClinicalTrials.gov